Ted Skolarus to Male
This is a "connection" page, showing publications Ted Skolarus has written about Male.
Connection Strength
2.366
-
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
Score: 0.048
-
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. Ann Fam Med. 2024 Jan-Feb; 22(1):5-11.
Score: 0.046
-
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer. Urology. 2024 02; 184:135-141.
Score: 0.046
-
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. Cancer. 2023 10 15; 129(20):3326-3333.
Score: 0.045
-
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer Med. 2023 03; 12(6):6945-6955.
Score: 0.044
-
Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncol Pract. 2023 05; 19(5):e763-e772.
Score: 0.043
-
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy. JNCI Cancer Spectr. 2022 05 02; 6(3).
Score: 0.041
-
Prostate cancer clinical trial completion: The role of geography. Contemp Clin Trials. 2021 12; 111:106600.
Score: 0.040
-
Factors influencing treatment of veterans with advanced prostate cancer. Cancer. 2021 07 01; 127(13):2311-2318.
Score: 0.038
-
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105.
Score: 0.036
-
Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy. Urol Oncol. 2020 04; 38(4):255-261.
Score: 0.035
-
Characterizing the Benign Prostatic Hyperplasia Literature: A Bibliometric Analysis. Urology. 2020 Feb; 136:202-211.
Score: 0.035
-
Catheter management after benign transurethral prostate surgery: RAND/UCLA Appropriateness Criteria. Am J Manag Care. 2019 12 01; 25(12):e366-e372.
Score: 0.035
-
Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Med. 2019 12; 8(18):7903-7912.
Score: 0.035
-
Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program. JAMA Netw Open. 2019 11 01; 2(11):e1916008.
Score: 0.035
-
Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration. Cancer Med. 2019 05; 8(5):2686-2702.
Score: 0.033
-
Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial. J Clin Oncol. 2019 05 20; 37(15):1326-1335.
Score: 0.033
-
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT). Implement Sci. 2018 11 29; 13(1):144.
Score: 0.033
-
Characterising potential bone scan overuse amongst men treated with radical prostatectomy. BJU Int. 2019 07; 124(1):55-61.
Score: 0.033
-
Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation. Cancer. 2018 10 15; 124(20):3971-3974.
Score: 0.032
-
Dissecting Surgeon Behavior: Leveraging the Theoretical Domains Framework to Facilitate Evidence-based Surgical Practice. Ann Surg. 2018 03; 267(3):432-434.
Score: 0.031
-
The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int. 2018 04; 121(4):558-564.
Score: 0.030
-
Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care. Urology. 2017 Dec; 110:92-97.
Score: 0.030
-
Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D. J Oncol Pract. 2017 08; 13(8):e694-e702.
Score: 0.030
-
Enhancing prostate cancer survivorship care through self-management. Urol Oncol. 2017 09; 35(9):564-568.
Score: 0.029
-
Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017 04 18; 18(1):181.
Score: 0.029
-
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care. Urology. 2017 06; 104:77-83.
Score: 0.029
-
Variation in readmission expenditures after high-risk surgery. J Surg Res. 2017 06 01; 213:60-68.
Score: 0.029
-
Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology. 2017 06; 104:131-136.
Score: 0.029
-
Providing prostate cancer survivorship care in Japan: Implications from the USA care model. Int J Urol. 2016 11; 23(11):906-915.
Score: 0.028
-
Treatment of ureteral anastomotic strictures with reimplantation and survival after cystectomy and urinary diversion. Urol Oncol. 2017 01; 35(1):33.e1-33.e9.
Score: 0.028
-
The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval. Eur Urol Focus. 2018 09; 4(5):711-717.
Score: 0.028
-
Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7. Eur Urol. 2016 06; 69(6):e125-6.
Score: 0.027
-
Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int. 2016 09; 118(3):372-8.
Score: 0.026
-
Editorial comment. Urology. 2015 Mar; 85(3):627-8.
Score: 0.025
-
Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology. 2015 Jan; 85(1):101-5.
Score: 0.025
-
Understanding hospital readmission intensity after radical cystectomy. J Urol. 2015 May; 193(5):1500-6.
Score: 0.025
-
Androgen-deprivation-associated bone disease. Curr Opin Urol. 2014 Nov; 24(6):601-7.
Score: 0.025
-
American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014 Jul-Aug; 64(4):225-49.
Score: 0.024
-
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer. 2014 May 01; 120(9):1409-16.
Score: 0.023
-
Quality of prostate cancer care among rural men in the Veterans Health Administration. Cancer. 2013 Oct 15; 119(20):3629-35.
Score: 0.023
-
Editorial comment. Urology. 2013 Apr; 81(4):751.
Score: 0.022
-
Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology. 2013 Feb; 81(2):354-7.
Score: 0.022
-
Monitoring quality of life among prostate cancer survivors: the feasibility of automated telephone assessment. Urology. 2012 Nov; 80(5):1021-6.
Score: 0.021
-
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011 Dec; 78(6):1345-9.
Score: 0.020
-
Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality. Cancer. 2012 Jun 01; 118(11):2837-45.
Score: 0.020
-
Primary care perspectives on prostate cancer survivorship: implications for improving quality of care. Urol Oncol. 2013 Aug; 31(6):727-32.
Score: 0.020
-
Primary care perspectives on prostate cancer screening. Nurse Pract. 2011 Jun; 36(6):39-44.
Score: 0.019
-
Understanding early functional recovery after robotic prostatectomy. Surg Innov. 2012 Mar; 19(1):5-10.
Score: 0.019
-
The delivery of prostate cancer care in the United States: implications for delivery system reform. J Urol. 2010 Dec; 184(6):2279-84.
Score: 0.019
-
Does robotic technology mitigate the challenges of large prostate size? Urology. 2010 Nov; 76(5):1117-21.
Score: 0.018
-
The economic burden of prostate cancer survivorship care. J Urol. 2010 Aug; 184(2):532-8.
Score: 0.018
-
Regional differences in early stage bladder cancer care and outcomes. Urology. 2010 Aug; 76(2):391-6.
Score: 0.018
-
Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. J Am Coll Surg. 2009 Aug; 209(2):248-53.
Score: 0.017
-
Measurement of benign prostatic hyperplasia treatment effects on male sexual function. Int J Impot Res. 2009 Sep-Oct; 21(5):267-74.
Score: 0.017
-
Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol. 2008 Jul; 22(7):1485-9.
Score: 0.016
-
The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol. 2008 Feb; 179(2):439-43; discussion 443-4.
Score: 0.015
-
The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol. 2007 Nov; 4(11):605-14.
Score: 0.015
-
Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients. JAMA Netw Open. 2024 Jul 01; 7(7):e2422281.
Score: 0.012
-
Attitudes and barriers toward video visits in surgical care: Insights from a nationwide survey among surgeons. Surgery. 2024 Jul; 176(1):115-123.
Score: 0.012
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
Score: 0.012
-
Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2024 Jun; 188:80-86.
Score: 0.012
-
Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study. Cancer Med. 2024 Jan; 13(1):e6847.
Score: 0.012
-
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 01; 20(1):59-68.
Score: 0.011
-
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice. J Urol. 2023 Nov; 210(5):771-777.
Score: 0.011
-
Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamide. Cancer Med. 2023 08; 12(15):16490-16501.
Score: 0.011
-
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. Eur Urol. 2023 05; 83(5):393-401.
Score: 0.011
-
Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel. J Sex Med. 2022 11; 19(11):1655-1669.
Score: 0.011
-
Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. J Urol. 2022 09; 208(3):600-608.
Score: 0.010
-
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer. Nat Rev Urol. 2022 05; 19(5):263-279.
Score: 0.010
-
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study. Prostate Cancer Prostatic Dis. 2023 06; 26(2):287-292.
Score: 0.010
-
Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient-reported outcomes. BJU Int. 2022 07; 130(1):84-91.
Score: 0.010
-
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results. Cancer. 2022 Apr 01; 128(7):1513-1522.
Score: 0.010
-
Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care. Urology. 2022 02; 160:161-167.
Score: 0.010
-
Improving Guideline Adherence in Urology. Eur Urol Focus. 2022 09; 8(5):1545-1552.
Score: 0.010
-
Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021 09; 155:70-76.
Score: 0.010
-
Understanding Active Surveillance for Prostate Cancer. JCO Oncol Pract. 2021 11; 17(11):e1678-e1687.
Score: 0.010
-
Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82.
Score: 0.010
-
Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions. J Gen Intern Med. 2021 02; 36(2):447-454.
Score: 0.009
-
Demand for Surgical Procedures Following COVID-19: The Need for Operational Strategies That Optimize Resource Utilization and Value. Ann Surg. 2020 10; 272(4):e272-e274.
Score: 0.009
-
Reconsidering the Trade-offs of Prostate Cancer Screening. N Engl J Med. 2020 09 24; 383(13):1289-1290.
Score: 0.009
-
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
Score: 0.009
-
The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder Cancer. Urology. 2020 11; 145:106-112.
Score: 0.009
-
Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration. Urol Oncol. 2020 09; 38(9):734.e1-734.e10.
Score: 0.009
-
Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data. JCO Clin Cancer Inform. 2020 07; 4:614-622.
Score: 0.009
-
A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool. Cancer Med. 2020 07; 9(14):5143-5154.
Score: 0.009
-
Resurrecting immortal-time bias in the study of readmissions. Health Serv Res. 2020 04; 55(2):273-276.
Score: 0.009
-
Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 06; 18(3):201-209.e2.
Score: 0.009
-
Reply by Authors. J Urol. 2020 02; 203(2):421.
Score: 0.009
-
Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract. 2019 10; 15(10):e863-e869.
Score: 0.009
-
Implications of Cystectomy Travel Distance for Hospital Readmission and Survival. Clin Genitourin Cancer. 2019 12; 17(6):e1171-e1180.
Score: 0.009
-
Characterising 'bounce-back' readmissions after radical cystectomy. BJU Int. 2019 12; 124(6):955-961.
Score: 0.009
-
External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer. J Urol. 2019 09; 202(3):518-524.
Score: 0.009
-
Adoption of Abiraterone and Enzalutamide by Urologists. Urology. 2019 09; 131:176-183.
Score: 0.008
-
Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery. Ann Surg. 2019 05; 269(5):873-878.
Score: 0.008
-
Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469.
Score: 0.008
-
Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
Score: 0.008
-
Role of Post-Acute Care on Hospital Readmission After High-Risk Surgery. J Surg Res. 2019 02; 234:116-122.
Score: 0.008
-
Population Analysis of Male Urethral Stricture Management and Urethroplasty Success in the United States. Urology. 2019 01; 123:258-264.
Score: 0.008
-
Michigan Appropriate Perioperative (MAP) criteria for urinary catheter use in common general and orthopaedic surgeries: results obtained using the RAND/UCLA Appropriateness Method. BMJ Qual Saf. 2019 01; 28(1):56-66.
Score: 0.008
-
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
Score: 0.008
-
Predictors and Cost of Readmission in Total Knee Arthroplasty. J Arthroplasty. 2018 09; 33(9):2759-2763.
Score: 0.008
-
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Urology. 2018 06; 116:68-75.
Score: 0.008
-
The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration. J Urol. 2018 09; 200(3):541-548.
Score: 0.008
-
Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):376-386.
Score: 0.008
-
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer. 2018 02 01; 124(3):563-570.
Score: 0.008
-
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. BMC Cancer. 2017 Oct 02; 17(1):664.
Score: 0.008
-
The State of Men's Health Services in the Veterans Health Administration. Curr Urol Rep. 2017 Sep 18; 18(11):88.
Score: 0.008
-
Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2018 04; 73(4):491-498.
Score: 0.007
-
Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial. J Urol. 2017 09; 198(3):600-607.
Score: 0.007
-
Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115.
Score: 0.007
-
Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population. Urology. 2017 04; 102:92-99.
Score: 0.007
-
Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. J Clin Oncol. 2016 10 10; 34(29):3586-3587.
Score: 0.007
-
Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care. 2016 Sep; 22(9):569-75.
Score: 0.007
-
Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60.
Score: 0.007
-
Negative information-seeking experiences of long-term prostate cancer survivors. J Cancer Surviv. 2016 12; 10(6):1089-1095.
Score: 0.007
-
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy. Urol Oncol. 2016 09; 34(9):415.e1-6.
Score: 0.007
-
Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol. 2016 08; 70(2):209-10.
Score: 0.007
-
Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 2016 01; 14(1):19-30.
Score: 0.007
-
A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy. J Urol. 2016 May; 195(5):1362-1367.
Score: 0.007
-
Expectant management of veterans with early-stage prostate cancer. Cancer. 2016 Feb 15; 122(4):626-33.
Score: 0.007
-
Preparing Patients and Partners for Recovery From the Side Effects of Prostate Cancer Surgery: A Group Approach. Urology. 2016 Feb; 88:36-42.
Score: 0.007
-
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015 Aug; 116(2):179-84.
Score: 0.006
-
Veterans Affairs Telemedicine: Bringing Urologic Care to Remote Clinics. Urology. 2015 Aug; 86(2):255-60.
Score: 0.006
-
Reply: To PMID 26168998. Urology. 2015 Aug; 86(2):260-1.
Score: 0.006
-
Are we targeting the right outcome for sexual health after prostate cancer treatment? Eur Urol. 2015 Oct; 68(4):550-1.
Score: 0.006
-
Survivorship and improving quality of life in men with prostate cancer. Eur Urol. 2015 Sep; 68(3):374-83.
Score: 0.006
-
Reducing PSA-Based Prostate Cancer Screening in Men Aged?75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med. 2015 Aug; 30(8):1133-9.
Score: 0.006
-
What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples' sexual recovery after surgery for prostate cancer. J Sex Med. 2015 Feb; 12(2):494-504.
Score: 0.006
-
Technology diffusion and prostate cancer quality of care. Urology. 2014 Nov; 84(5):1066-72.
Score: 0.006
-
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. Urology. 2014 Aug; 84(2):373-8.
Score: 0.006
-
Exploring the role of the partner in couples' sexual recovery after surgery for prostate cancer. Support Care Cancer. 2014 Sep; 22(9):2509-15.
Score: 0.006
-
Adherence to performance measures and outcomes among men treated for prostate cancer. J Urol. 2014 Sep; 192(3):743-8.
Score: 0.006
-
Validating electronic cancer quality measures at Veterans Health Administration. Am J Manag Care. 2014; 20(12):1041-7.
Score: 0.006
-
Regional variation in quality of prostate cancer care. J Urol. 2014 Apr; 191(4):957-62.
Score: 0.006
-
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95.
Score: 0.006
-
Technology diffusion and diagnostic testing for prostate cancer. J Urol. 2013 Nov; 190(5):1715-20.
Score: 0.006
-
Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. Urology. 2012 Dec; 80(6):1236-42.
Score: 0.005
-
Certificate of need legislation and the dissemination of robotic surgery for prostate cancer. J Urol. 2013 Jan; 189(1):80-5.
Score: 0.005
-
Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. Urology. 2012 Nov; 80(5):1015-20.
Score: 0.005
-
Comparative effectiveness of external-beam radiation approaches for prostate cancer. Eur Urol. 2014 Jan; 65(1):162-8.
Score: 0.005
-
Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood). 2012 Apr; 31(4):750-9.
Score: 0.005
-
Identifying better practices for early-stage bladder cancer. Med Care. 2011 Dec; 49(12):1112-7.
Score: 0.005
-
Editorial comment. Urology. 2011 Feb; 77(2):279.
Score: 0.005
-
Understanding prostate cancer spending growth among Medicare beneficiaries. Urology. 2011 Feb; 77(2):326-31.
Score: 0.005
-
Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology. 2011 Feb; 77(2):385-90.
Score: 0.005
-
Delays in diagnosis and bladder cancer mortality. Cancer. 2010 Nov 15; 116(22):5235-42.
Score: 0.005
-
Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14.
Score: 0.004